Target Price | $382.57 |
Price | $333.38 |
Potential | 14.76% |
Number of Estimates | 21 |
21 Analysts have issued a price target Sherwin-Williams 2026 . The average Sherwin-Williams target price is $382.57. This is 14.76% higher than the current stock price. The highest price target is $420.00 25.98% , the lowest is $283.00 15.11% . | |
A rating was issued by 30 analysts: 16 Analysts recommend Sherwin-Williams to buy, 11 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sherwin-Williams stock has an average upside potential 2026 of 14.76% . Most analysts recommend the Sherwin-Williams stock at Purchase. |
23 Analysts have issued a sales forecast Sherwin-Williams 2025 . The average Sherwin-Williams sales estimate is $23.7b . This is 2.49% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $24.0b 4.00% , the lowest is $23.1b 0.05% .
This results in the following potential growth metrics:
2024 | $23.1b | 0.20% |
---|---|---|
2025 | $23.7b | 2.49% |
2026 | $24.9b | 4.98% |
2027 | $26.3b | 5.67% |
2028 | $27.0b | 2.91% |
24 Analysts have issued an Sherwin-Williams EBITDA forecast 2025. The average Sherwin-Williams EBITDA estimate is $4.7b . This is 7.38% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.0b 13.75% , the lowest is $4.4b 0.25% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $4.4b | 3.63% |
---|---|---|
2025 | $4.7b | 7.54% |
2026 | $5.1b | 8.81% |
2027 | $5.6b | 9.52% |
2028 | $5.6b | 0.97% |
2024 | 19.04% | 3.42% |
---|---|---|
2025 | 19.98% | 4.93% |
2026 | 20.71% | 3.65% |
2027 | 21.46% | 3.62% |
2028 | 20.65% | 3.77% |
11 Sherwin-Williams Analysts have issued a net profit forecast 2025. The average Sherwin-Williams net profit estimate is $2.9b . This is 7.64% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.1b 15.17% , the lowest is $2.6b 3.41% .
This results in the following potential growth metrics and future Net Margins:
2024 | $2.7b | 14.05% |
---|---|---|
2025 | $2.9b | 7.64% |
2026 | $3.2b | 12.56% |
2027 | $3.7b | 14.53% |
2028 | $3.8b | 3.55% |
2024 | 11.48% | 13.82% |
---|---|---|
2025 | 12.05% | 4.98% |
2026 | 12.92% | 7.22% |
2027 | 14.01% | 8.44% |
2028 | 14.10% | 0.64% |
11 Analysts have issued a Sherwin-Williams forecast for earnings per share. The average Sherwin-Williams EPS is $11.36 . This is 7.68% higher than earnings per share in the financial year 2024. The highest EPS forecast is $12.15 15.17% , the lowest is $10.19 3.41% .
This results in the following potential growth metrics and future valuations:
2024 | $10.55 | 14.05% |
---|---|---|
2025 | $11.36 | 7.68% |
2026 | $12.78 | 12.50% |
2027 | $14.64 | 14.55% |
2028 | $15.16 | 3.55% |
Current | 31.61 | 8.24% |
---|---|---|
2025 | 29.36 | 7.12% |
2026 | 26.08 | 11.17% |
2027 | 22.77 | 12.69% |
2028 | 21.99 | 3.43% |
Based on analysts' sales estimates for 2025, the Sherwin-Williams stock is valued at an EV/Sales of 4.08 and an P/S ratio of 3.54 .
This results in the following potential growth metrics and future valuations:
Current | 4.18 | 4.24% |
---|---|---|
2025 | 4.08 | 2.48% |
2026 | 3.88 | 4.75% |
2027 | 3.67 | 5.36% |
2028 | 3.57 | 2.83% |
Current | 3.63 | 3.48% |
---|---|---|
2025 | 3.54 | 2.43% |
2026 | 3.37 | 4.75% |
2027 | 3.19 | 5.36% |
2028 | 3.10 | 2.83% |
Sherwin-Williams...
Analyst | Rating | Action | Date |
---|---|---|---|
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 09 2025 |
Citigroup |
Buy
➜
Buy
|
Unchanged | Apr 08 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Apr 07 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 03 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 01 2025 |
Jefferies |
Buy
➜
Hold
|
Downgrade | Mar 10 2025 |
Citigroup |
➜
Buy
|
Unchanged | Feb 26 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 09 2025 |
Unchanged
Citigroup:
Buy
➜
Buy
|
Apr 08 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Apr 07 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 03 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Apr 01 2025 |
Downgrade
Jefferies:
Buy
➜
Hold
|
Mar 10 2025 |
Unchanged
Citigroup:
➜
Buy
|
Feb 26 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.